Key result
Diabetes is linked to ~2.3-fold higher odds of achieving target LDL-C in treated CHD.
Why the study?
Rates of LDL-C target value attainment in patients with stable coronary heart disease in Belgium were not well documented, and predictors of attainment were unclear.
Cross-Sectional (n=409)
Answers are grounded in this paper and cite their sources.
Low attainment signals care gaps in Belgian CHD; observational data leaves open targeted strategies for women and nondiabetics.
Objectives: To document the frequency and predictors of low-density lipoprotein cholesterol (LDL-C) target value attainment among patients with coronary heart disease (CHD) in Belgium.Methods: The second Dyslipidemia International Study (DYSIS II) was an observational study of the prevalence of dyslipidemias and lipid target value attainment. Patients in this analysis were aged ≥ 18, had documented CHD, and had a full lipid profile. Use of lipid-lowering therapy (LLT), lipid profile, and LDL-C target value attainment (< 70 mg/dL) were assessed cross-sectionally at the enrollment visit. The distribution of LLTs was assessed among treated patients. Multivariate logistic regression was used to identify variables predictive of LDL-C target value attainment in treated patients.Results: We identified 409 patients with CHD in Belgium, 387 (94.6%) of whom were on LLT at the time of the lipid profile. Among treated patients, the rate of LDL-C target value attainment was 40.6%, and statin monotherapy was the most commonly used LLT (79.3%). Among users of statin monotherapy or combination therapy, simvastatin was the most commonly used treatment (41.6% of patients). Diabetes was associated with higher odds of LDL-C target value attainment (OR 2.29, 95% CI 1.33–3.93), and female gender was associated with lower odds (OR 0.48, 95% CI 0.24–0.97).Conclusion: Rates of LDL-C target value attainment are low in patients with CHD in Belgium. Intensifying statin therapy or combining it with non-statins is essential in Belgian patients for optimal LDL-C reduction.
No takes yet. Share an insight, caveat, or question.
Hermans et al. (2018) conducted a cross-sectional in Coronary heart disease (n=409). Diabetes vs. No diabetes was evaluated on LDL-C target value attainment (< 70 mg/dL) (OR 2.29, 95% CI 1.33-3.93). Only 40.6% of treated patients with coronary heart disease in Belgium attained the LDL-C target of </dL; diabetes was associated with higher odds of attainment while female gender was associated with lower odds.
Synapse has enriched 10 related papers. Consider them for comparative context: